Executive Chairman
Dr Graeme L Blackman
BSc(Hons), PhD, FRACI, FTSE

Formerly Professor of Pharmaceutical Chemistry, Victorian College of Pharmacy. Extensive experience in research and development and commercial scientific consulting.

Responsibilities - Executive Chairman of the Board, Member of Nomination Committee, Member of the Remuneration Committee.

Dr. Blackman is the founder of IDT and majority shareholder. He has over 25 years experience in the international pharmaceutical industry including the research and development sector. Dr. Blackman is a member of key government and pharmaceutical industry policy committees, and a board member of Medicines Australia. He is also the Chairman of the Pharmaceutical Industry Action Agenda.

Responsibilities - Executive Chairman of the Board, Member of Nomination Committee, Member of the Remuneration Committee. Dr. Blackman is the founder of IDT and majority shareholder. He has over 25 years experience in the international pharmaceutical industry including the research and development sector. Dr. Blackman is a member of key government and pharmaceutical industry policy committees, and a board member of Medicines Australia. He is also the Chairman of the Pharmaceutical Industry Action Agenda.

Alan D Blackman
BA(Hons), LLB(Hons)

Experience: Practising lawyer with considerable experience in corporate and commercial law.

Responsibilities: Non executive. Member of Nomination Remuneration and Audit Committees.

Robert Burnet
BA, MBA, MATEM, FPSA(Hon)

Formerly director of Clayton and Berwick Campus, Monash University. Experienced in academic administration generally and the administration of pharmaceutical teaching
and research in particular.
He is currently a Crisis Management Consultant.

Responsibilities - Non executive. Member of Nomination Remuneration and Audit Committees.

Deputy Chairman
Geoffrey F Lord
BEco (Hons), MBA (Distn), ASSA, AICD

Formerly Chief Executive and Deputy Chairman of Elders Resources Limited. Current Directorships: Presently Chairman and Chief Executive of Belgravia Group Pty Ltd, Executive Chairman of UXC Limited, Chairman of LCM Litigation Fund, Maxitrans Industries Limited, KLM Group Limited and Northern Energy Corporation Limited

Responsibilities: Non executive. Member of Nomination and Remuneration Committees.

Managing Director
Dr Robyn Elliott
BSc(Hons), PhD

Dr Robyn Elliott has a PhD in chemistry and has been working in the pharmaceutical industry since 1986. Robyn has had extensive experience in the development and international registration of active pharmaceutical ingredients and pharmaceutical finished products.

Robyn's involvement with all aspects of the drug development process at an international level has given her an understanding of each component of the process and an insight into the needs of potential clients who look to IDT for expert advice and support. Since joining IDT in 1995 she has been paramount in guiding and developing IDT into the exciting and successful company it is today.

Dr Geoffrey N Vaughan
AO, MSc, PhD, FRACI, FTSE

Formerly National Manager of the Therapeutic Goods Administration. Former Chairman of the Co-operative Research Centres Committee, Member of Industry Research and Development Board of the the Department of Industry, Tourism & Resources and Councillor of Questacon, the National Science and Technology Centre.